BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/27/2023 11:23:27 AM | Browse: 207 | Download: 508
 |
Received |
|
2022-11-19 12:33 |
|
Peer-Review Started |
|
2022-11-19 12:35 |
|
First Decision by Editorial Office Director |
|
2023-01-03 06:57 |
|
Return for Revision |
|
2023-01-03 06:57 |
|
Revised |
|
2023-01-16 16:22 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-02-10 03:37 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-02-10 17:30 |
|
Articles in Press |
|
2023-02-10 17:30 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-02-14 00:01 |
|
Publish the Manuscript Online |
|
2023-02-27 11:23 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Fecal microbiota transplantation as potential first-line treatment for patients with Clostridioides difficile infection and prior appendectomy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jing-Wen Zhao, Bing Chang and Li-Xuan Sang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Li-Xuan Sang, MD, PhD, Professor, Department of Gastroenterology, Shengjing Hospital of China Medical University, No. 39 Gliding Road, Tiexi District, Shenyang 110022, Liaoning Province, China. sanglixuan2008@163.com |
| Key Words |
Clostridioides difficile infection; Appendectomy; Fecal microbiota transplantation; Intestinal microbiota; Toxic megacolon; Colectomy |
| Core Tip |
The fecal microbiota transplantation (FMT) is a universally approved treatment plan for recurrent Clostridioides difficileinfection (CDI). We believe that early FMT is a better choice for patients with CDI and prior appendectomy even if they are not diagnosed as recurrent CDI. FMT can change the composition of patients' intestinal microbiota in a lasting way to prevent worse outcomes. |
| Publish Date |
2023-02-27 11:23 |
| Citation |
Zhao JW, Chang B, Sang LX. Fecal microbiota transplantation as potential first-line treatment for patients with Clostridioides difficile infection and prior appendectomy. World J Gastrointest Surg 2023; 15(2): 303-306 |
| URL |
https://www.wjgnet.com/ 1948-9366/full/v15/i2/303.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v15.i2.303 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
